2% Lidocaine Hci Injection, Solution
Product Images NDC 51662-1326

16 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for 2% Lidocaine Hci (NDC 51662-1326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Pouch Label (5166213262 Label)

Serialized Pouch Label (5166213262 Label)
Label for 2% LIDOCAINE HCI INJECTION, USP 1000mg/50mL (20mg/mL) in a 50mL vial. The label includes the NDC number 51662-1326-2, a lot number, and an expiration date of 2021-06-01. It also states the product is for infiltration and nerve block, is prescription only, and is distributed by HF Acquisition Co LLC, Mukilteo, WA.*
FDA Label Image

Serialized Rfid Label (5166213263 Rfid Label)

Serialized Rfid Label (5166213263 Rfid Label)
A small rectangular white label with black text and a barcode. It includes identifiers such as (01) 00351662132630, (17) 210601, (21) 12345, (10) ABC123, and states 'See manufacturer's package insert.' The label notes distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275, and has a vertical 'RX ONLY' marking on the right edge.*
FDA Label Image

Serialized Case Label (5166213263 Label)

Serialized Case Label (5166213263 Label)
Label for 2% Lidocaine HCl Injection, USP 1000 mg/50 mL (20 mg/mL) in a 50 mL vial, sold as a box of 25. The label includes National Drug Code (NDC) 51662-1326-3, lot number, and expiration date of 2021-06-01. Distributed by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA.*
FDA Label Image

Description (Description Table 1)

Description (Description Table 1)
Data table presenting the concentrations of lidocaine HCl (anhydrous) and sodium chloride in various lidocaine HCl injection solutions. Concentrations are shown for 0.50%, 1%, 1.50%, and 2% lidocaine HCl, with corresponding mg/mL values for lidocaine HCl and sodium chloride listed in each column.*
FDA Label Image

1 (Dosage 1)

1 (Dosage 1)
A table presenting different strength options and packaging types for lidocaine injection solutions. It lists 1% strength in 30 mL single-dose teartop vials, 1.5% strength in 20 mL single-dose ampuls, and 2% strength in 10 mL single-dose ampuls.*
FDA Label Image

2 (Dosage 2)

2 (Dosage 2)
A table presenting Lidocaine Hydrochloride Injection, USP dosage guidelines without epinephrine. It lists various procedures such as infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks with corresponding recommended concentrations (%), volumes (mL), and total doses (mg). The table details specific procedures like brachial, dental, intercostal, epidural, and surgical anesthesia, specifying dosage ranges for each.*
FDA Label Image

1 (How Supplied 1)

1 (How Supplied 1)
A data table listing different units of sale and concentrations for various Lidocaine HCl products, including NDC codes, packaging types such as glass teartop vials and glass ampuls, and concentrations ranging from 0.5% to 2%. The table details units like single-dose, trays, cartons, and cases, with corresponding drug amounts in mg and volumes in mL.*
FDA Label Image

2 (How Supplied 2)

2 (How Supplied 2)
A table presenting unit of sale, concentration, clam cell packaging, and individual packaging details for lidocaine injection solutions. It lists multiple NDCs with concentrations of 1% and 2%, available in clam cells or ampuls, detailing quantities per carton or bundle.*
FDA Label Image

3 (How Supplied 3)

3 (How Supplied 3)
A data table listing multiple units of sale for Lidocaine products, including NDC codes, tray sizes, concentrations, and package types. Concentrations range from 0.5% to 2%, with details on vial or bottle formats, and quantities such as trays of 25.*
FDA Label Image
FDA Label Image

Label 1 (Label 1 51662 1326 1 March 2021 Update)

Label 1 (Label 1 51662 1326 1 March 2021 Update)
Label of 2% Lidocaine HCl Injection, USP, 20 mg/mL solution in a 50 mL multiple-dose vial by HF Acquisition Co LLC, DBA HealthFirst. The label states use for infiltration and nerve block, specifying it is not for epidural and caudal use and contains preservative. It lists active ingredients and preservatives, storage instructions, and distributor details from Hospira Inc.*
FDA Label Image

Label 2 (Label 2 51662 1326 1 March 2021 Update)

Label 2 (Label 2 51662 1326 1 March 2021 Update)
Label for 2% Lidocaine HCl Injection, USP, 1000 mg/50 mL (20 mg/mL) solution in a 50 mL multiple-dose vial. The label indicates it is for infiltration and nerve block, cautions against epidural and caudal use, and notes the presence of preservative. Distributed by Hospira, Inc., this product contains lidocaine hydrochloride, sodium chloride, methylparaben, and may include HCl or NaOH for pH adjustment.*
FDA Label Image

Vial Label (Multidose Vial Label)

Vial Label (Multidose Vial Label)
Label for 2% Lidocaine HCl Injection, USP, multiple-dose vial, 1000 mg/50 mL (20 mg/mL) strength. The label indicates it is for infiltration and nerve block, not for epidural and caudal use, and contains preservative. Manufactured by Hospira, Inc., Lake Forest, IL.*
FDA Label Image

Serialized Label (Serialized 51662 1326 1)

Serialized Label (Serialized 51662 1326 1)
2% Lidocaine HCl injection solution, 50 mL multi-dose vial. The label indicates 1000 mg per 50 mL (20 mg/mL) strength. Distributed by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The vial has a blue cap and a white background label with blue text.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of lidocaine hydrochloride monohydrate showing a substituted aromatic ring with two methyl groups and an amide linkage attached to a diethylamino group, along with hydrochloride and water molecules.*
FDA Label Image

Serialized Label (Serialized Label 51662 1326 1 March 2021)

Serialized Label (Serialized Label 51662 1326 1 March 2021)
A close-up of a product label with a GS1 DataMatrix barcode and text including a GS1 Application Identifier code (01) with the number 00351662132616, a date code (17) 200701, a serial number (21) 4880047365, and a batch number (10) 91-036-DK. The label advises to see the manufacturer's package insert and states the product is distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275. 'RX ONLY' appears vertically on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.